BOSTON, Oct. 21, 2020 (GLOBE NEWSWIRE) -- RA Capital Management, LP (“RA Capital”) has held a first and final closing of its second venture fund, RA Capital Nexus Fund II, L.P. (“Nexus II”), raising ...

Investors tracking insider transactions may have noted a substantial purchase of shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) by RA Capital Management, L.P., a notable healthcare and life sciences ...

– RA Capital and OMERS Life Sciences provide up to $250 million loan facility to commercial-stage biopharma company ARS Pharma to propel further growth – BOSTON, Sept. 30, 2025 /PRNewswire/ -- RA ...

BOSTON—RA Capital Management, a prominent investment firm, has significantly increased its stake in Sionna Therapeutics , Inc. (NASDAQ: SION) by purchasing common stock valued at $20.25 million. This ...

The comprehensiveness of clinical guidelines is a major determinant of their usefulness, but covering a broad range of topics in depth can prove difficult. In contrast to guidelines for RA management ...

Please provide your email address to receive an email when new articles are posted on . The term “game-changer” is thrown around freely in the English language vernacular. But it is unlikely that ...

According to the review, the most important novel developments were related to the repositioning of old drugs in the context of treat-to-target (T2T) therapy and new long-term safety information on ...